ScalientIQ·For PE-Backed Operators

The Baseline Nobody Handed You

What a read-only look at your go-to-market surfaces in less than a week, priced in dollars.

When you took the seat, someone handed you a number. Nobody handed you a go-to-market baseline: where pipeline leaks, which tools feed a revenue decision and which quietly do not, and what any of it is worth. Most operators spend two or three quarters finding that out by hand, one surprise at a time.

Scalient IQ reads what is already in your CRM and the rest of your revenue stack, scores it, and prices what it finds. Read-only. Nothing installed, nothing written back, nothing new for your team to maintain.

The read
Full Funnel Report Less than a week
Two lenses, one read · CEO and CRO

Sales. Where pipeline leaks, whether deal stages mean what they say, buying-committee coverage on your real deals, and how much of the forecast rests on CRM data that will not hold up.

Demand. Whether inbound gets followed up and how fast, where the funnel loses people between channels, and whether you show up at all when a buyer asks ChatGPT, Perplexity, Gemini, or Claude for a vendor like you.

Every dimension scored, each finding priced against the pipeline it puts at risk, plus a board-grade view of GTM efficiency sitting above the score.

The full baseline
Also available: Stack Health ReportLess than a week

A narrower first step if you want one: a single Signal-to-Spend number on what your go-to-market software spend actually returns. Smallest access ask of the two.

What comes back

A readout, not a login. Findings ranked by dollar impact, each traced to the data behind it, and a short list of what to fix first. Written for your operating team and forwardable to your board without translation.

Then the read stays on. Always On measures every finding against the baseline, so the next leak shows up while it is still recoverable, not a quarter later.

Nobody has to log in

Read-only access to HubSpot or Salesforce and whatever else sits in the stack. Nothing installed, nothing written back, access revocable at any time. We read the stack you already have rather than asking you to change it, and a diagnostic engagement clears procurement in weeks, not quarters.

Why it holds up with your board

Nothing in it is a black box, so the findings hold up under the follow-up questions your board and your sponsor will ask. McKinsey's June 2026 study of 471 PE-backed companies argued for the same sequence: establish where a company actually is before deciding where to invest. Better to walk in with that number than to be handed one.

Next step

Thirty minutes. Bring whoever owns revenue operations. We walk a sample report, you decide whether it is worth running, and if the answer is no, that is a fine outcome. No deck.

Scalient IQ
info@scalientiq.com · scalientiq.com